PremiumCompany AnnouncementsAtea Pharmaceuticals Announces Board Changes and Share Buyback Atea Pharmaceuticals board authorizes $25M share repurchase program Atea Pharmaceuticals says strategic alternatives process ‘ongoing’ PremiumThe FlyRadoff-JEC Group nominates candidates to Atea Pharmaceuticals board Atea Pharmaceuticals issues statement regarding director nominations Atea Pharmaceuticals announces presentation of bemnifosbuvir preclinical data PremiumPre-EarningsAVIR Upcoming Earnings Report: What to Expect? Atea Pharmaceuticals Appoints Arthur Kirsch as Director Atea Pharmaceuticals appoints Arthur Kirsch to board of directors 
